The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
about
Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient PopulationImpact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancerThe association between adiposity and breast cancer recurrence and survival: A review of the recent literatureEffect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review.Body mass index and aromatase inhibitors: a step forward in individualizing therapy for breast cancer patients?Weight changes in postmenopausal breast cancer survivors over 2 years of endocrine therapy: a retrospective chart review.Adjuvant aromatase inhibitor options in overweight and obese postmenopausal women with breast cancer.Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole.Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.
P2860
Q36114823-E70FAC59-E70C-444C-A8B2-2721A8163C4DQ37182285-98F765DA-D78B-4CB2-A87A-B2A41D8F3E6AQ37579337-738D4B67-90E3-4BE1-AD3E-CB3381E7DD04Q38239596-E42D5187-526B-4767-820E-E0747E1DE4FDQ38838419-1AB92916-F713-43BD-8E6E-5023BEA07F05Q39117032-D8B3DB41-EF84-4A72-A097-0136506C8F35Q43924246-D8D05920-8CF5-4996-9C81-0D926F2D67D0Q46733261-C45DD837-85CF-4235-ADF8-8E36E452218AQ48241850-C934F5E1-271F-4C9C-AC8B-4096CDE105A0Q53618240-7CE7CDEE-218B-4129-B639-365FDF27B816
P2860
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The predictive impact of body ...... the randomised ABCSG-6a trial.
@en
The predictive impact of body ...... the randomised ABCSG-6a trial.
@nl
type
label
The predictive impact of body ...... the randomised ABCSG-6a trial.
@en
The predictive impact of body ...... the randomised ABCSG-6a trial.
@nl
prefLabel
The predictive impact of body ...... the randomised ABCSG-6a trial.
@en
The predictive impact of body ...... the randomised ABCSG-6a trial.
@nl
P2093
P2860
P356
P1476
The predictive impact of body ...... the randomised ABCSG-6a trial
@en
P2093
B Mlineritsch
H Samonigg
P2860
P2888
P304
P356
10.1038/BJC.2013.367
P407
P577
2013-07-18T00:00:00Z